ZHANG Jing  

  • Chief Physician, Doctoral Supervisor
  • Department: Gastroenterology
  • Research Area: Internal medicine (degestive system diseases)
  • Research Interests: Pathologenesis and treatment of gastric mucosal lesions
  • Contact: zhangjing5522724@sjtu.edu.cn
  • PhD from Shanghai Jiao Tong University School of Medicine, 2013
  • Postdoctoral Fellow, Digestive Disease Research Institute, the Chinese University of Hong Kong, 2018
  • Deputy Director, Department of Gastroenterology, Shanghai Sixth People's Hospital.
  • Leader of the Gastroenterology Department, Fengxian District Central Hospital
  • Young Committee Member of the Digestive Disease Committee of the Chinese Association of Integrative Medicine

All co-first authors should be marked with a superscript "#", and corresponding authors and co-corresponding authors should be marked with a superscript "*"

  1. Yu Y#, Yang YL#, Chen XY, Chen ZY, Zhu JS*, Zhang J*. Helicobacter Pylori-Enhanced hnRNPA2B1 Coordinates with PABPC1 to Promote Non-m6A Translation and Gastric Cancer Progression. Adv Sci. 2024;11(30):e2309712. IF 14.1
  2. Chen XY#, Yang YL#, Yu Y, Chen ZY, Fan HN, Zhang J*, Zhu JS*. CircUGGT2 downregulation by METTL14-dependent m6A modification suppresses gastric cancer progression and cisplatin resistance through interaction with miR-186-3p/MAP3K9 axis. Pharmacol Res. 2024;204:107206. IF 10.5
  3. Fan HN#, Chen ZY#, Chen XY, Chen M, Yi YC, Zhu JS*, Zhang J*. METTL14-mediated m6A modification of circORC5 suppresses gastric cancer progression by regulating miR-30c-2-3p/AKT1S1 axis. Mol Cancer. 2022;21(1):51. IF 37.3
  4. Zhang J#, Hou L#, Liang R#, Chen X, Zhang R, Chen W, Zhu J*. CircDLST promotes the tumorigenesis and metastasis of gastric cancer by sponging miR-502-5p and activating the NRAS/MEK1/ERK1/2 signaling. Mol. Cancer, 2019, 18: 80. IF 15.302
  5. Wang H#, Chen W#, Jin M, Hou L, Chen X, Zhang R, Zhang J*, Zhu J, CircSLC3A2 functions as an oncogenic factor in hepatocellular carcinoma by sponging miR-490-3p and regulating PPM1F expression. Mol. Cancer, 2018, 17: 165. IF 10.679
  6. Zhang J, Huang JZ, Zhang YQ, Zhang X, Zhao LY, Li CG, Zhou YF, Wei H, Yu J. Microtubule associated protein 9 inhibits liver tumorigenesis by suppressing ERCC3. EBioMedicine, 2020, 53: 102701. IF 8.143
  7. Zhang J#, Liu H#, Hou L, Wang G, Zhang R, Huang Y, Chen X, Zhu J*. Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression. Mol. Cancer, 2017, 16: 151. IF 7.776
  8. Huang Y#, Zhang J#*, Hou L, Wang G, Liu H, Zhang R, Chen X, Zhu J*. LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway. J Exp Clin Cancer Res. 2017;36(1):194. IF 6.217
  • 07/01/2025-06/30/2028
    Shanghai Natural Science Foundation, 25ZR1401288, ¥200,000, Research on the Effect and Mechanism of Oridonin on Gastric Cancer Invasion and Metastasis by Regulating the Polarization State of Tumor-Associated Macrophages through the hnRNPA2B1/hsa_circ_402515/RSPO4-103aa/S100A8 Axis
    Role: Project leader
  • 01/01/2025-12/31/2027
    Seed Program for Medical New Technology Research and Transformation of the Shanghai Municipal Health Commission, 2024ZZ2048,, ¥200,000, Clinical Application of Detachable Magnetically controlled Capsule Endoscopy in the Diagnosis of Gastroesophageal Reflux Disease.
    Role: Project leader
  • 6/30/2021-6/30/2024
    Shanghai Natural Science Foundation, 21ZR1448700, ¥200,000, Exploring the anti-gastric cancer effect and mechanism of dihydroartemisinin based on the m6A demethylase ALKBH5/circARHGEF12/miR-130b-5p axis
    Role: Project leader
  • 01/01/2019-12/31/2022
    National Natural Science Foundation of China, 81873143, ¥560,000, The role and molecular mechanism of toosendanin in regulating the invasion and metastasis of gastric cancer through the circ_0032627/miR-502-5p Axis
    Role: Project leader
  1. Zhang Jing (1/1), an outstanding expert in the field of gastric cancer under the People's Good Doctor Jinshan Camellia Program, People's Daily Online People's Health, 2023.
  2. Zhang Jing (2/8), Second Prize for Science and Technology of Integrated Traditional Chinese and Western Medicine in Shanghai, Shanghai Society of Integrated Traditional Chinese and Western Medicine, 2021.
  3. Zhang Jing (1/8), Third Prize for Science and Technology of Integrated Traditional Chinese and Western Medicine in China, Chinese Society of Integrated Traditional Chinese and Western Medicine, 2024.
  • Zhang Jing, "Gastrointestinal Microecology and Digestive System Diseases", published by Tianjin Science and Technology Press, ISBN: 978-7-5576-8121-0
  • Zhang Jing (1/1), excellent model expert of the People's Good Doctor Jinshan Camellia Plan (in the field of gastric cancer), People's Health Network, 2023.
  • Zhu Jinshui, Zhang Jing et al (2021), Second Prize in Shanghai Integrated Traditional Chinese and Western Medicine Technology, Shanghai Association of Integrated Traditional Chinese and Western Medicine